MPWT
NVIV

MassMutual Private Wealth & Trust’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3
Closed -$4.42K – 1163
2018
Q2 		$4.42K Buy
+3
New +$16.5K ﹤0.01% 746

Other funds holding NVIV

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MassMutual Private Wealth & Trust's NVIV Position: Q3 2018 in Review

MassMutual Private Wealth & Trust sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q3 2018, closing a stake of 3 shares — an estimated $4.42K sold.

MassMutual Private Wealth & Trust first reported a position in NVIV in Q2 2018 and held it in 1 quarter. The position peaked at $4.42K in Q2 2018. 15 funds tracked by Wall St. Rank hold NVIV as of Q3 2018.

  • MassMutual Private Wealth & Trust reported no remaining InVivo Therapeutics Holdings Corp position as of Q3 2018 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 3 InVivo Therapeutics Holdings Corp shares in Q3 2018, an estimated $4.42K.
  • MassMutual Private Wealth & Trust first reported a position in InVivo Therapeutics Holdings Corp in Q2 2018 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's InVivo Therapeutics Holdings Corp position peaked at $4.42K in Q2 2018.
  • 15 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q3 2018.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2018, filed 9 Nov 2018.